What is oncology Pharma's (onph) stock symbol?
The real reason for the low price of ONPH over past few months/years is the hedge funds shorting 998% of the stock float and driving it down.
What will the onph stock price be in the future?
Oncology Pharma Inc () Stock Market info Recommendations: Buy or sell Oncology Pharma stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Oncology Pharma share forecasts, stock quote and buy / sell signals below.According to present data Oncology Pharma's ONPH shares and potentially its market environment have been in …
Is oncology Pharma Inc (onph) a good long-term investment?
Find the latest Oncology Pharma Inc. (ONPH) stock quote, history, news and other vital information to help you with your stock trading and investing.
Are oncology Pharma insiders selling their shares?
Apr 12, 2022 · The company has a collaboration and licensing agreement with Kalos Therapeutics Inc. for exploring treatment opportunities of the COVID-19 virus. The company was formerly known as SourcingLink.net Inc. and changed its name to Oncology Pharma Inc. in June 2019. Oncology Pharma Inc. was incorporated in 1993 and is based in San Francisco, California.
"Should I invest in Oncology Pharma stock?" "Should I trade "ONPH" stock today?"
According to our live Forecast System, Oncology Pharma Inc stock is an awesome long-term (1-year)...
What is the Oncology Pharma stock price / share price today?
The Oncology Pharma stock price is 3.660 USD today.
Will Oncology Pharma stock price grow / rise / go up?
Yes. The ONPH stock price can go up from 3.660 USD to 11.378 USD in...
Is it profitable to invest in Oncology Pharma stock?
Yes. The long-term earning potential is + 210.86 % in one year.
Will ONPH stock price fall / drop?
No. See above .
What will Oncology Pharma stock price be worth in five years (2027)?
The ONPH ("ONPH" ) future stock price will be 42.658 USD .
Will ONPH stock price crash?
According to our analysis, this will not happen.
Will Oncology Pharma stock price hit 10 USD price in a year?
Yes, within a year. See above .
Will Oncology Pharma stock price hit 20 USD price in a year?
Not within a year. See above .
Are investors shorting Oncology Pharma?
Oncology Pharma saw a increase in short interest in February. As of February 15th, there was short interest totaling 563,400 shares, an increase of...
Who are Oncology Pharma's key executives?
Oncology Pharma's management team includes the following people: Mr. Chuck Wagner , Pres, Treasurer & Chairman Mr. George Malesek , Interim Chie...
Who are some of Oncology Pharma's key competitors?
Some companies that are related to Oncology Pharma include Upland Software (UPLD) , ChannelAdvisor (ECOM) , Pathfinder Acquisition (PFDR) , Red...
What is Oncology Pharma's stock symbol?
Oncology Pharma trades on the OTCMKTS under the ticker symbol "ONPH."
How do I buy shares of Oncology Pharma?
Shares of ONPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBul...
What is Oncology Pharma's stock price today?
One share of ONPH stock can currently be purchased for approximately $4.01.
How much money does Oncology Pharma make?
Oncology Pharma has a market capitalization of $135.52 million.
How many employees does Oncology Pharma have?
Oncology Pharma employs 1 workers across the globe.
What is Oncology Pharma's official website?
The official website for Oncology Pharma is www.oncology-pharma.com .
Signals & Forecast
Support, Risk & Stop-loss
There are mixed signals in the stock today. The Oncology Pharma Inc. stock holds a buy signal from the short-term moving average; at the same time, however, the long-term average holds a general sell signal.
Is Oncology Pharma Inc. stock A Buy?
Oncology Pharma Inc. finds support from accumulated volume at $17.98 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
Oncology Pharma's Co-Development Agreement Pursues Strategic and Direct Objectives
Oncology Pharma Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.
Oncology Pharma, Inc. Executes Co-Development Agreement with NanoSmart Pharmaceuticals, Inc
SAN FRANCISCO, CA / ACCESSWIRE / August 23, 2021 / Oncology Pharma, Inc. (OTC PINK:ONPH) defines its objective and strategy for recently signed Co-Development deal.
Oncology Pharma, Inc. To Move to Conducting Trials on Licensed IP
SAN FRANCISCO, CA / ACCESSWIRE / August 19, 2021 / Oncology Pharma Inc. (OTC PINK:ONPH) With much anticipation, Oncology Pharma, Inc.
Oncology Pharma, Inc. is Entering Into the Next Phase of its Growth and Expansion Phase
SAN FRANCISCO, CA / ACCESSWIRE / July 20, 2021 / Oncology Pharma Inc. (OTC PINK:ONPH) Oncology Pharma, Inc.
Oncology Pharma, Inc. Eyes Collaboration with Patent Opportunities Amongst Its Licensed Intellectual Properties
SAN FRANCISCO, CA / ACCESSWIRE / June 30, 2021 / Oncology Pharma Inc. (OTC PINK:ONPH) Oncology Pharma, Inc.
Oncology Pharma and Ribera Solutions Release White Paper Regarding Patient Engagement and Retention Platform
SAN FRANCOSCO, CA / ACCESSWIRE / June 15, 2021 / Oncology Pharma Inc. (OTC PINK:ONPH) Oncology Pharma, Inc.
Oncology Pharma, Inc. Is Pursuing the Development of Its Small Molecule Drug for the Treatment of Colon Cancer
SAN FRANCISCO, CA / ACCESSWIRE / June 9, 2021 /Oncology Pharma Inc. (OTC PINK:ONPH) Oncology Pharma, Inc.
What stocks does MarketBeat like better than Oncology Pharma?
SAN FRANCISCO, CA / ACCESSWIRE / May 18, 2021 / Oncology Pharma Inc. (OTC PINK:ONPH) Oncology Pharma, Inc.
Are investors shorting Oncology Pharma?
Wall Street analysts have given Oncology Pharma a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Oncology Pharma wasn't one of them.
Who are some of Oncology Pharma's key competitors?
Oncology Pharma saw a increase in short interest during the month of August. As of August 13th, there was short interest totaling 82,600 shares, an increase of 32.2% from the July 29th total of 62,500 shares. Based on an average trading volume of 446,000 shares, the days-to-cover ratio is currently 0.2 days.#N#View Oncology Pharma's Short Interest.
How do I buy shares of Oncology Pharma?
Some companies that are related to Oncology Pharma include Grid Dynamics (GDYN), Cognyte Software (CGNT), QAD (QADA), QAD (QADB), Golden Nugget Online Gaming (GNOG), Sapiens International (SPNS), SecureWorks (SCWX), Zeta Global (ZETA), SkillSoft (SKIL), Materialise (MTLS), NCC Group (NCCGF), Upland Software (UPLD), Avid Technology (AVID), Opera (OPRA) and ON24 (ONTF).#N#View all of ONPH's competitors..
What is Oncology Pharma's stock price today?
Shares of ONPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.#N#Compare Top Brokerages Here.
Where are Oncology Pharma's headquarters?
One share of ONPH stock can currently be purchased for approximately $16.16.
How can I contact Oncology Pharma?
Oncology Pharma is headquartered at 16855 WEST BERNARDO DRIVE SUITE 260, SAN DIEGO CA, 92127.
Oncology Pharma Media Sentiment
Oncology Pharma's mailing address is 16855 WEST BERNARDO DRIVE SUITE 260, SAN DIEGO CA, 92127. The company can be reached via phone at (415) 869-1038.
Media Coverage
Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.
Oncology Pharma (OTCMKTS ONPH) News Headlines Today
We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.
What goes up must come down
Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm.
What happened
Travis Hoium has been writing for fool.com since July 2010 and covers the solar industry, renewable energy, and gaming stocks among other things. Follow @TravisHoium
So what
After an incredible run higher over the past six months, fuel cell stocks came crashing to earth today along with the rest of the stock market. FuelCell Energy ( NASDAQ:FCEL) shares fell as much as 18.7%, Ballard Power Systems ( NASDAQ:BLDP) dropped 17%, and Plug Power ( NASDAQ:PLUG) plunged 12.6% at its low.
Now what
When markets are going up, volatility can work in fuel cell investors' favor. But when markets go down, volatility can hit stocks hard. And that's exactly what's happening with fuel cell stocks today.